Your browser doesn't support javascript.
loading
High Uptake of Respiratory Syncitial Virus Prevention for Neonates in a Military Treatment Facility.
Homo, Richelle L; Groberg, Andrew; Donahue, Megan; Halverson, Dustin; Wooten, Anna; Ponnapakkam, Adharsh.
Afiliación
  • Homo RL; Brooke Army Medical Center, Division of Neonatal and Perinatal Medicine, Department of Pediatrics, San Antonio, TX. Electronic address: RichelleHomo@gmail.com.
  • Groberg A; Brooke Army Medical Center, Division of Neonatal and Perinatal Medicine, Department of Pediatrics, San Antonio, TX.
  • Donahue M; Brooke Army Medical Center, Department of Pediatrics, San Antonio, TX.
  • Halverson D; Brooke Army Medical Center, Department of Pediatrics, San Antonio, TX.
  • Wooten A; Brooke Army Medical Center, Department of Pediatrics, San Antonio, TX.
  • Ponnapakkam A; Brooke Army Medical Center, Department of Pediatrics, San Antonio, TX.
J Pediatr ; 273: 114144, 2024 Jun 12.
Article en En | MEDLINE | ID: mdl-38876155
ABSTRACT
We investigated the uptake of nirsevimab for infants and the bivalent respiratory syncytial virus prefusion F (RSVPreF) vaccine for pregnant persons as measures for RSV prevention during an infant's birth hospitalization in a military treatment facility. We found >85% uptake between October 2023 to February 2024. These data may aid health systems plan for future RSV seasons.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Pediatr Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Pediatr Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos